Key result
Multilevel factors at the patient and transplant center levels were independently associated with immunosuppressive nonadherence, which had an overall prevalence of 39.7% among kidney transplant patients.
Why the study?
Immunosuppressive nonadherence impairs kidney transplant outcomes, but multilevel correlates independent of patient financial burden had not been evaluated across a large public transplantation system.
Cross-Sectional (n=1,105)
Yes
Immunosuppressive nonadherence in kidney transplant patients is highly prevalent and associated with both patient-level behaviors and transplant center practice patterns, highlighting the need for multilevel interventions.
Answers are grounded in this paper and cite their sources.
Nonadherence prevalence nearing 40% linked to multilevel factors warrants monitoring; leaves open whether interventions improve outcomes in kidney transplant recipients.
BACKGROUND: Immunosuppressive nonadherence is a risk factor for worse outcomes after kidney transplantation (KT). Brazil, having the world's largest public, fully covered transplantation system and the second-highest KT volume worldwide, provides a unique setting for studying multilevel correlates of nonadherence (patient, healthcare provider, transplant center, and healthcare system levels) independent of patients' financial burden. METHODS: By applying a multistage sampling approach, we included 1105 patients from 20 KT centers. Nonadherence to immunosuppressives (implementation phase) was defined as any deviation in taking or timing adherence and dose reduction assessed by the Basel Assessment of Adherence to Immunosuppressive Medications Scale. Based on Bronfenbrenner's ecological model, we assessed multilevel factors using established instruments and measures specifically developed for this study and analyzed their independent contribution to nonadherence by performing sequential logistic regression analysis. RESULTS: The nonadherence prevalence rate was 39.7%. The following factors were independently associated with nonadherence: Patient level-having a stable partner (odds ratio [OR]: 0.75; confidence interval [CI]: 0.58-0.97), nonadherence to appointments (OR: 2.98; CI: 2.03-4.39), and nonadherence to physical activity recommendations (OR: 1.84; CI: 1.38-2.46); and transplant center level-satisfaction with the waiting room structure (OR: 0.54; CI: 0.42-0.71), consultation >30 minutes (OR: 1.60; CI: 1.19-2.14), adequacy of the consultation frequency (OR: 0.62; CI: 0.43-0.90), and centers with >500 beds (OR: 0.58; CI: 0.46-0.73). CONCLUSIONS: As the first multicenter study assessing multilevel correlates of nonadherence in KT, our findings point to the need for multilevel interventions beyond the patient level, targeting transplant center practice patterns as an approach to tackle nonadherence.
No takes yet. Share an insight, caveat, or question.
Sanders‐Pinheiro et al. (2020) conducted a cross-sectional in Kidney transplantation (n=1,105). Multilevel factors (patient and transplant center characteristics) was evaluated on Immunosuppressive nonadherence (implementation phase) (95% CI 36.8-42.6). Multilevel factors at the patient and transplant center levels were independently associated with immunosuppressive nonadherence, which had an overall prevalence of 39.7% among kidney transplant patients.
Synapse has enriched 10 related papers. Consider them for comparative context: